ESMO Breast Cancer 2025

ESMO Breast Cancer 2025 will take place in Munich, Germany, from 14 to 17 May 2025, as well as online, through a dedicated virtual platform.

Join us at this focused event that will bring together international experts in the field to explore the latest innovations, discuss cutting-edge treatments and collaborate on strategies to improve patient outcomes.

We aim to provide fresh insights into the most recent advancements in breast cancer diagnosis, treatment and survivorship, by offering a comprehensive overview of the current landscape of breast cancer care.

Share experiences, exchange ideas and forge meaningful collaborations with renowned experts in the field.

Scientific Committee Co-Chairs

Erika Hamilton, Nashville TN, USA

Masakazu Toi, Tokyo Japan

Nicholas Turner, London UK

The ESMO Breast Cancer 2025 will take place from 14 to 17 May 2025 in Munich, Germany, with sessions available also through a dedicated platform.

Registration includes:

• Participation in scientific and educational sessions
• Opportunities to network with speakers, faculty and peers
• Access to the poster area
• Interaction with the industry partners in the exhibition area
• Participation in the Industry Satellite Symposia
• Live-streamed sessions and sessions on-demand on the virtual congress platform
• Access to the meeting resources on OncologyPRO after the event
• The ESMO Daily Reporter
• Coffee breaks

Registration fees and deadlines

Individual registration will remain open for the duration of the congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines.

ESMO membership must be active ten (10) working days prior to the registration, to be eligible for the reduced member registration fee. Please visit the membership page on esmo.org to check eligibility criteria, benefits, and to complete the membership application.

*Applicable to ESMO members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.

**ESMO members must be under 40 and in training to qualify for this fee.

The ESMO Breast Cancer 2025 programme is online!

Learning objectives

• To update your knowledge on the fast-developing field of breast cancer
• To understand recent developments in novel diagnostics, biomarkers, and treatments among the different subtypes of breast cancer
• To be informed on risk-adapted strategies for optimising treatment of breast cancer
• To be updated on the impact of antibody drug conjugates and immunotherapy on treatment landscape for breast cancer
• To understand special considerations for different subgroups of patients with breast cancer

Audience

The ESMO Breast Cancer is a congress designed for breast cancer researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and care. It will be a multidisciplinary meeting with a global scope, involving top scientists.

Accreditation

ESMO-MORA: The ESMO Breast Cancer 2025 programme has been accredited with 22 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.